Samsung Engineering Co. has received a letter of intent for a 1.2 trillion-won methanol plant order from Malaysian petrochemical company, Sarawak PetChem.
Under the deal, Samsung Engineering will build the plant, which will have a daily capacity of 5,000 tons of methanol, in Bintulu, Sarawak by 2023.
The plant's design would be based on Air Liquide E&C's Lurgi MegaMethanol technology.
Samsung Engineering, which won the contract from Sarawak Petrochem for front-end engineering design (FEED) in April 2019, entered into a partnership with Air Liquide E&C to carry out the FEED study for the project.
Sarawak Petrochem awarded the first Early Work contract to Sarawak Petrochem in November 2019.
Samsung Engineering, an industrial plant affiliate of Samsung Group, has obtained about 9 trillion won worth of plant orders so far this year, comprising 86 percent of its annual target of 10.5 trillion won.
The engineering firm currently has a 17 trillion-won order backlog.


Instagram Outage Disrupts Thousands of U.S. Users
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Washington Post Publisher Will Lewis Steps Down After Layoffs
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



